Australia Lung Cancer Screening Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Australia Lung Cancer Screening Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Australia Lung Cancer Screening Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Lung Cancer Incidence
5.1.2 Increasing Government Support

5.2 Market Opportunities

5.2.1 Structured Lung Cancer Screening Program

5.3 Future Trends

5.3.1 Mobile Lung Cancer Screening Truck

5.4 Impact of Drivers and Restraints

6. Australia Lung Cancer Screening Market Regional Analysis

6.1 Australia Lung Cancer Screening Market Overview

6.2 Australia Lung Cancer Screening Market Revenue 2020-2030 (US$ Million)

6.3 Australia Lung Cancer Screening Market Forecast Analysis

7. Australia Lung Cancer Screening Market Analysis – by Cancer Type

7.1 Non-Small Cell Lung Cancer

7.1.1 Overview
7.1.2 Non-Small Cell Lung Cancer: Australia Lung Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Small Cell Lung Cancer

7.2.1 Overview
7.2.2 Small Cell Lung Cancer: Australia Lung Cancer Screening Market – Revenue and Forecast to 2031 (US$ Million)

8. Australia Lung Cancer Screening Market Analysis – by Technology

8.1 Low-Dose Computed Tomography

8.1.1 Overview
8.1.2 Low-Dose Computed Tomography: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Chest X-Ray

8.2.1 Overview
8.2.2 Chest X-Ray: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Liquid Biopsy

8.3.1 Overview
8.3.2 Liquid Biopsy: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

9. Australia Lung Cancer Screening Market Analysis – by Age group

9.1 50 & Older and Below 50

9.1.1 Overview
9.1.2 Liquid Biopsy: Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

10. Australia Lung Cancer Screening Market – Australia Analysis

10.1 Australia

10.1.1 Australia Lung Cancer Screening Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 Australia Lung Cancer Screening Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Australia : Australia Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Australia : Australia Lung Cancer Screening Market Breakdown, by Cancer Type
10.1.1.1.2 Australia : Australia Lung Cancer Screening Market Breakdown, by Technology
10.1.1.1.3 Australia : Australia Lung Cancer Screening Market Breakdown, by Age group

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Australia Lung Cancer Screening Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Intelerad Medical Systems Incorporated

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Nuance Communications Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 GE HealthCare Technologies Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Medtronic Plc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Canon Medical Systems Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Koninklijke Philips NV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 CVS Health

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 bioAffinity Technologies, Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 LungLife AI, Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Lung Screen Australia Pty Ltd

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights